These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28751101)

  • 21. Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.
    El Khoury P; Roussel R; Fumeron F; Abou-Khalil Y; Velho G; Mohammedi K; Jacob MP; Steg PG; Potier L; Ghaleb Y; Elbitar S; Ragot S; Andreata F; Caligiuri G; Hadjadj S; Boileau C; Marre M; Abifadel M; Varret M; Hansel B
    Diabetes Obes Metab; 2018 Apr; 20(4):943-953. PubMed ID: 29205760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
    Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL; ;
    Diabetes Care; 2008 Apr; 31(4):811-22. PubMed ID: 18375431
    [No Abstract]   [Full Text] [Related]  

  • 23. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes.
    Epshteyn V; Morrison K; Krishnaswamy P; Kazanegra R; Clopton P; Mudaliar S; Edelman S; Henry R; Maisel A
    Diabetes Care; 2003 Jul; 26(7):2081-7. PubMed ID: 12832317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk.
    Hayashi M; Morioka T; Hatamori M; Kakutani Y; Yamazaki Y; Kurajoh M; Motoyama K; Mori K; Fukumoto S; Shioi A; Shoji T; Emoto M; Inaba M
    Diabetes Res Clin Pract; 2019 Feb; 148():160-168. PubMed ID: 30641171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria: rationale and effect on late-diabetic complications.
    Gaede PH
    Dan Med Bull; 2006 Aug; 53(3):258-84. PubMed ID: 17092449
    [No Abstract]   [Full Text] [Related]  

  • 26. Higher serum sialic acid in women than in men with NIDDM: possible relevance to increased cardiovascular risk in NIDDM women.
    Pickup JC; Roberts GA; Kehely AM; Pasapula C; Chusney GD; Mather HM
    Diabetes Care; 1997 Sep; 20(9):1496. PubMed ID: 9283808
    [No Abstract]   [Full Text] [Related]  

  • 27. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
    Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
    Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Cardiovascular Risk and Testing in Type 2 Diabetes.
    Saeed A; Ballantyne CM
    Curr Cardiol Rep; 2017 Mar; 19(3):19. PubMed ID: 28220465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes.
    Hamasaki H; Kawashima Y; Katsuyama H; Sako A; Goto A; Yanai H
    Sci Rep; 2017 Aug; 7(1):7041. PubMed ID: 28765572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes.
    Sommeijer DW; Hansen HR; van Oerle R; Hamulyak K; van Zanten AP; Meesters E; Spronk HM; ten Cate H
    J Thromb Haemost; 2006 Mar; 4(3):574-80. PubMed ID: 16371118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased red cell aggregation in diabetes mellitus: association with cardiovascular risk factors.
    MacRury SM; Lennie SE; McColl P; Balendra R; MacCuish AC; Lowe GD
    Diabet Med; 1993; 10(1):21-6. PubMed ID: 8435983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients.
    Targher G; Bertolini L; Rodella S; Tessari R; Zenari L; Lippi G; Arcaro G
    Diabetes Care; 2007 Aug; 30(8):2119-21. PubMed ID: 17519430
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study.
    Hansen CS; Jensen TM; Jensen JS; Nawroth P; Fleming T; Witte DR; Lauritzen T; Sandbaek A; Charles M; Fleischer J; Vistisen D; Jørgensen ME
    Diabet Med; 2015 Jun; 32(6):778-85. PubMed ID: 25761542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of age on glucose tolerance and cardiovascular risk factors--results of the Diabetes Infobus tour 1998/99 ].
    Fasching P
    Acta Med Austriaca Suppl; 2002; 56():17-22. PubMed ID: 12436708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum irisin levels in new-onset type 2 diabetes.
    Choi YK; Kim MK; Bae KH; Seo HA; Jeong JY; Lee WK; Kim JG; Lee IK; Park KG
    Diabetes Res Clin Pract; 2013 Apr; 100(1):96-101. PubMed ID: 23369227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: the end of the beginning.
    Reaven G
    Circulation; 2005 Nov; 112(20):3030-2. PubMed ID: 16286599
    [No Abstract]   [Full Text] [Related]  

  • 38. B-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitus.
    Dawson A; Jeyaseelan S; Morris AD; Struthers AD
    Am J Cardiol; 2005 Oct; 96(7):933-4. PubMed ID: 16188519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microalbuminuria: is it a valid predictor of cardiovascular risk?
    Tagle R; Acevedo M; Vidt DG
    Cleve Clin J Med; 2003 Mar; 70(3):255-61. PubMed ID: 12678217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
    Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
    Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.